Viridian Therapeutics Inc (VRDN) stock news · rev $70.8M
Viridian Therapeutics Inc (VRDN) is a biotechnology company listed on US.
This VRDN news page leads with what Viridian Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for VRDN yet. We will not pad this page with generic market recap.
Latest reported VRDN revenue for 2025-12-31 was $70.8M. Net income was -$342.6M. Revenue was up 23359.9% from 2024-12-31 to 2025-12-31. VRDN currently screens at market cap $1.39B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the VRDN stock page; for the tape open the quote page.
VRDN stock news FAQ
What are VRDN's latest revenue and net income?
Latest cached Viridian Therapeutics Inc (VRDN) revenue for Dec 31, 2025 was $70.8M. Net income was -$342.6M. Statements: https://lician.com/financials/vrdn
How did VRDN revenue change from the prior cached period?
Cached Viridian Therapeutics Inc (VRDN) revenue was up 23359.9% from $302.0K (Dec 31, 2024) to $70.8M (Dec 31, 2025). Statements: https://lician.com/financials/vrdn
What is VRDN's market cap?
Viridian Therapeutics Inc (VRDN) market cap is $1.39B on the latest cached fundamentals snapshot.
What kind of company is VRDN?
Viridian Therapeutics Inc (VRDN) is a biotechnology company listed on US.
Where is VRDN stock news listed?
Cached stock news for Viridian Therapeutics Inc (VRDN) is listed at https://lician.com/news/vrdn. Filings: https://lician.com/sec/vrdn
Not investment advice.